Literature DB >> 29751289

Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Pilar M Ferraro1, Charles Jester2, Christopher A Olm3, Katerina Placek2, Federica Agosta4, Lauren Elman5, Leo McCluskey5, David J Irwin2, John A Detre3, Massimo Filippi4, Murray Grossman2, Corey T McMillan6.   

Abstract

Amyotrophic lateral sclerosis (ALS) and the behavioral variant of frontotemporal dementia (bvFTD) commonly share the presence of transactive response DNA-binding protein 43 (TDP-43) inclusions. Structural magnetic resonance imaging studies demonstrated evidence for TDP-43 pathology spread, but while structural imaging usually reveals overt neuronal loss, perfusion imaging may detect more subtle neural activity alterations. We evaluated perfusion as an early marker for incipient pathology-associated brain alterations in TDP-43 proteinopathies. Cortical thickness (CT) and perfusion measurements were obtained in ALS (N = 18), pathologically and/or genetically confirmed bvFTD-TDP (N = 12), and healthy controls (N = 33). bvFTD showed reduced frontotemporal CT, hypoperfusion encompassing orbitofrontal and temporal cortices, and hyperperfusion in motor and occipital regions. ALS did not show reduced CT, but exhibited hypoperfusion in motor and temporal regions, and hyperperfusion in frontal and occipital cortices. Frontotemporal hypoperfusion and reduced CT correlated with cognitive and behavioral impairments as investigated using Mini-Mental State Examination and Philadelphia Brief Assessment of Cognition in bvFTD, and hypoperfusion in motor regions correlated with motor disability as measured by the ALS Functional Rating Scale-Revised in ALS. Hypoperfusion marked early pathologically involved regions, while hyperperfusion characterized regions of late pathological involvement. Distinct perfusion patterns may provide early markers of pathology distribution in TDP-43 proteinopathies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Frontotemporal dementia; Magnetic resonance imaging; Pathology; Perfusion; TDP-43

Mesh:

Substances:

Year:  2018        PMID: 29751289      PMCID: PMC5993674          DOI: 10.1016/j.neurobiolaging.2018.04.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  63 in total

1.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

2.  Comparing brain structural MRI and metabolic FDG-PET changes in patients with ALS-FTD: 'the chicken or the egg?' question.

Authors:  Venkateswaran Rajagopalan; Erik P Pioro
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-12-17       Impact factor: 10.154

3.  Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD).

Authors:  Johannes Brettschneider; Kelly Del Tredici; David J Irwin; Murray Grossman; John L Robinson; Jon B Toledo; Lubin Fang; Vivianna M Van Deerlin; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-01-10       Impact factor: 17.088

4.  Large-scale evaluation of ANTs and FreeSurfer cortical thickness measurements.

Authors:  Nicholas J Tustison; Philip A Cook; Arno Klein; Gang Song; Sandhitsu R Das; Jeffrey T Duda; Benjamin M Kandel; Niels van Strien; James R Stone; James C Gee; Brian B Avants
Journal:  Neuroimage       Date:  2014-05-29       Impact factor: 6.556

5.  What drives MRI-measured cortical atrophy in multiple sclerosis?

Authors:  V Popescu; R Klaver; P Voorn; Y Galis-de Graaf; D L Knol; J W R Twisk; A Versteeg; G J Schenk; P Van der Valk; F Barkhof; H E De Vries; H Vrenken; J J G Geurts
Journal:  Mult Scler       Date:  2015-01-12       Impact factor: 6.312

6.  Open Access Series of Imaging Studies (OASIS): cross-sectional MRI data in young, middle aged, nondemented, and demented older adults.

Authors:  Daniel S Marcus; Tracy H Wang; Jamie Parker; John G Csernansky; John C Morris; Randy L Buckner
Journal:  J Cogn Neurosci       Date:  2007-09       Impact factor: 3.225

7.  Longitudinal assessment of grey matter contraction in amyotrophic lateral sclerosis: A tensor based morphometry study.

Authors:  Federica Agosta; Maria Luisa Gorno-Tempini; Elisabetta Pagani; Stefania Sala; Domenico Caputo; Michele Perini; Ilaria Bartolomei; Maria Elena Fruguglietti; Massimo Filippi
Journal:  Amyotroph Lateral Scler       Date:  2009-06

Review 8.  Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis.

Authors:  John Ravits
Journal:  Exp Neurol       Date:  2014-08-06       Impact factor: 5.330

9.  Altered Brain Network in Amyotrophic Lateral Sclerosis: A Resting Graph Theory-Based Network Study at Voxel-Wise Level.

Authors:  Chaoyang Zhou; Xiaofei Hu; Jun Hu; Minglong Liang; Xuntao Yin; Lin Chen; Jiuquan Zhang; Jian Wang
Journal:  Front Neurosci       Date:  2016-05-10       Impact factor: 4.677

10.  Screening for cognition and behaviour changes in ALS.

Authors:  Sharon Abrahams; Judith Newton; Elaine Niven; Jennifer Foley; Thomas H Bak
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-06-19       Impact factor: 4.092

View more
  5 in total

1.  Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion.

Authors:  Sai Sampath Thammisetty; Laurence Renaud; Vincent Picher-Martel; Yuan Cheng Weng; Frédéric Calon; Stephan Saikali; Jean-Pierre Julien; Jasna Kriz
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

2.  Brain mural cell loss in the parietal cortex in Alzheimer's disease correlates with cognitive decline and TDP-43 pathology.

Authors:  P Bourassa; C Tremblay; J A Schneider; D A Bennett; F Calon
Journal:  Neuropathol Appl Neurobiol       Date:  2020-02-11       Impact factor: 8.090

3.  Structural magnetic resonance imaging findings and histopathological correlations in motor neuron diseases-A systematic review and meta-analysis.

Authors:  Charlotte Zejlon; Dominik Nakhostin; Sebastian Winklhofer; Athina Pangalu; Zsolt Kulcsar; Sebastian Lewandowski; Johannes Finnsson; Fredrik Piehl; Caroline Ingre; Tobias Granberg; Benjamin Victor Ineichen
Journal:  Front Neurol       Date:  2022-08-30       Impact factor: 4.086

4.  18F-FDG-PET correlates of aging and disease course in ALS as revealed by distinct PVC approaches.

Authors:  Pilar M Ferraro; Cristina Campi; Alberto Miceli; Claudia Rolla-Bigliani; Matteo Bauckneht; Lorenzo Gualco; Michele Piana; Cecilia Marini; Lucio Castellan; Silvia Morbelli; Claudia Caponnetto; Gianmario Sambuceti; Luca Roccatagliata
Journal:  Eur J Radiol Open       Date:  2022-01-13

5.  Combining structural and metabolic markers in a quantitative MRI study of motor neuron diseases.

Authors:  Antonietta Canna; Francesca Trojsi; Federica Di Nardo; Giuseppina Caiazzo; Gioacchino Tedeschi; Mario Cirillo; Fabrizio Esposito
Journal:  Ann Clin Transl Neurol       Date:  2021-08-02       Impact factor: 4.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.